Virological Escape in HCV Genotype-1-Infected Patients Receiving Daclatasvir plus Ribavirin and Peginterferon Alfa-2A or Alfa-2B
暂无分享,去创建一个
K. Chayama | N. Izumi | O. Yokosuka | J. Toyota | N. Kawada | H. Kumada | Y. Osaki | F. Mcphee | E. Hughes | Hideaki Watanabe | N. Zhou | H. Ishikawa | D. Hernandez | Fei Yu | Joseph M. Ueland | A. Monikowski